跳至主要内容
临床试验/NCT05009186
NCT05009186Unknown不适用

Changing of PSA With Covid-19

Saglik Bilimleri Universitesi2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年4月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
2
主要终点
PSA value

研究概览

简要总结

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a worldwide pandemic in over 100 years. The disease caused by this newly discovered virus was called Covid-19. In this study, we aimed to evaluate changing of PSA value in patients with Covid-19.

详细描述

Patients with positive PCR test results were included in the study. The age of the patient and urea, leukocyte, hemoglobin, platelet, urea, and creatinine values of the patients were recorded. Urinalysis and urine culture were taken from all patients. Acute phase reactants such as sedimentation, C-reaktif protein (CRP), ferritin, and fibrinogen were measured both at the time the patients applied and three weeks after the patient recovered. PSA and free PSA were also measured in the same way. Patients whose symptoms improved and the PCR test result was negative were considered as recovered.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
45 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Male patients (>45 and <70 years of age) positive PCR test results were included in the study

排除标准

  • The patients <45 and >70 years of age who described lower urinary tract symptoms who had urinary tract infection who a history of prostate biopsy and previous high level of PSA who history of prostatitis were excluded.

结局指标

主要结局

PSA value

时间窗: 2 months

prostate specific antigen

次要结局

  • Ferritin, CRP(2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Omer Gokhan Doluoglu

Ankara Training and Research Hospital

Saglik Bilimleri Universitesi

研究点 (2)

Loading locations...

相似试验